Tommi Lehtonen

Chief Executive Officer at

Blueprint Genetics Oy

56 year

7 connections

Consumer Services

Commercial Services

Health Technology

Profile

Tommi Lehtonen founded Blueprint Genetics Oy in 2008, where he is working as Chief Executive Officer from 2008 and Hedera Dx SA in 2021, where he is working as Chief Executive Officer from 2021.
Mr. Lehtonen also founded Whitevector Oy, where he worked as Managing Director.
Mr. Lehtonen received his graduate degree from the University of Helsinki.

Tommi Lehtonen active positions

Companies	Position	Start
Blueprint Genetics Oy Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases	Chief Executive Officer	31/12/2007
Hedera Dx SA Hedera Dx SA Packaged SoftwareTechnology Services Develops software for liquid biopsies	Chief Executive Officer	31/12/2020

All active positions of Tommi Lehtonen

Former positions of Tommi Lehtonen

Companies	Position	End
Whitevector Oy Whitevector Oy Miscellaneous Commercial ServicesCommercial Services Provides measuring and analysis social media	Founder	-

See the detail of Tommi Lehtonen's experience

Training of Tommi Lehtonen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tommi Lehtonen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Helsinki University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Whitevector Oy Whitevector Oy Miscellaneous Commercial ServicesCommercial Services Provides measuring and analysis social media	Commercial Services
Blueprint Genetics Oy Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases	Health Technology
Hedera Dx SA Hedera Dx SA Packaged SoftwareTechnology Services Develops software for liquid biopsies	Technology Services